BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 26360976)

  • 1. Utility of Contrast-enhanced Ultrasonography with Perflubutane for Determining Histologic Grade in Hepatocellular Carcinoma.
    Tada T; Kumada T; Toyoda H; Ito T; Sone Y; Kaneoka Y; Maeda A; Okuda S; Otobe K; Takahashi K
    Ultrasound Med Biol; 2015 Dec; 41(12):3070-8. PubMed ID: 26360976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of contrast-enhanced ultrasound with perflubutane for diagnosing the macroscopic type of small nodular hepatocellular carcinomas.
    Tada T; Kumada T; Toyoda H; Ito T; Sone Y; Kaneoka Y; Maeda A; Okuda S; Otobe K; Takahashi K
    Eur Radiol; 2014 Sep; 24(9):2157-66. PubMed ID: 24952601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrast-enhanced ultrasound with perflubutane microbubble agent: evaluation of differentiation of hepatocellular carcinoma.
    Takahashi M; Maruyama H; Ishibashi H; Yoshikawa M; Yokosuka O
    AJR Am J Roentgenol; 2011 Feb; 196(2):W123-31. PubMed ID: 21257852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of contrast-enhanced ultrasound washout rate in predicting hepatocellular carcinoma differentiation.
    Feng Y; Qin XC; Luo Y; Li YZ; Zhou X
    Ultrasound Med Biol; 2015 Jun; 41(6):1553-60. PubMed ID: 25747937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computer-aided diagnosis for estimating the malignancy grade of hepatocellular carcinoma using contrast-enhanced ultrasound: an ROC observer study.
    Sugimoto K; Shiraishi J; Tanaka H; Tsuchiya K; Aso K; Kobayashi Y; Iijima H; Moriyasu F
    Liver Int; 2016 Jul; 36(7):1026-32. PubMed ID: 26681659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intensity-Based Assessment of Microbubble-Enhanced Ultrasonography: Phase-Related Diagnostic Ability for Cellular Differentiation of Hepatocellular Carcinoma.
    Kondo T; Maruyama H; Kiyono S; Sekimoto T; Shimada T; Takahashi M; Ogasawara S; Suzuki E; Ooka Y; Tawada A; Chiba T; Kanai F; Yokosuka O
    Ultrasound Med Biol; 2015 Dec; 41(12):3079-87. PubMed ID: 26371403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of combined gray-scale and perflubutane contrast-enhanced ultrasound for diagnosing early hepatocellular carcinomas: Comparison of well differentiated and distinctly nodular types.
    Tada T; Kumada T; Toyoda H; Sone Y; Kaneoka Y; Maeda A; Okuda S; Otobe K; Tsuji N
    Hepatol Res; 2016 Nov; 46(12):1214-1225. PubMed ID: 26860925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contrast-enhanced ultrasound of hepatocarcinogenesis in liver cirrhosis.
    Wu W; Chen MH; Sun M; Yan K; Yang W; Li JY
    Chin Med J (Engl); 2012 Sep; 125(17):3104-9. PubMed ID: 22932189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of primary and recurrent nodules in liver cirrhosis using contrast-enhanced ultrasound: which vascular criteria should be adopted?
    Leoni S; Piscaglia F; Granito A; Borghi A; Galassi M; Marinelli S; Terzi E; Bolondi L
    Ultraschall Med; 2013 Jun; 34(3):280-7. PubMed ID: 23616066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between contrast-enhanced intraoperative ultrasound using Sonazoid and histologic grade of resected hepatocellular carcinoma.
    Arita J; Hasegawa K; Takahashi M; Hata S; Shindoh J; Sugawara Y; Kokudo N
    AJR Am J Roentgenol; 2011 Jun; 196(6):1314-21. PubMed ID: 21606294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of vessel patterns on contrast-enhanced ultrasonography using a perflubutane-based contrast agent for the differential diagnosis of regenerative nodules from early hepatocellular carcinoma or high-grade dysplastic nodules in patients with chronic liver disease.
    Numata K; Fukuda H; Nihonmatsu H; Kondo M; Nozaki A; Chuma M; Morimoto M; Oshima T; Okada M; Murakami T; Takebayashi S; Maeda S; Inayama Y; Nakano M; Tanaka K
    Abdom Imaging; 2015 Oct; 40(7):2372-83. PubMed ID: 26099473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of local recurrence after treatment for hepatocellular carcinoma by contrast-enhanced ultrasonography using Sonazoid: comparison with dynamic computed tomography.
    Shiozawa K; Watanabe M; Takayama R; Takahashi M; Wakui N; Iida K; Sumino Y
    J Clin Ultrasound; 2010 May; 38(4):182-9. PubMed ID: 20232404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Degree of Contrast Washout on Contrast-Enhanced Ultrasound in Distinguishing Intrahepatic Cholangiocarcinoma from Hepatocellular Carcinoma.
    Han J; Liu Y; Han F; Li Q; Yan C; Zheng W; Wang J; Guo Z; Wang J; Li A; Zhou J
    Ultrasound Med Biol; 2015 Dec; 41(12):3088-95. PubMed ID: 26386477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of pathological features of hepatocellular carcinoma by contrast-enhanced ultrasonography: comparison with pathology on resected specimen.
    Ogawa S; Kumada T; Toyoda H; Ichikawa H; Kawachi T; Otobe K; Hibi T; Takeshima K; Kiriyama S; Sone Y; Tanikawa M; Hisanaga Y; Yamaguchi A; Isogai M; Kaneoka Y; Washizu J
    Eur J Radiol; 2006 Jul; 59(1):74-81. PubMed ID: 16545532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating histologic differentiation of hepatitis B virus-related hepatocellular carcinoma using intravoxel incoherent motion and AFP levels alone and in combination.
    Shan Q; Chen J; Zhang T; Yan R; Wu J; Shu Y; Kang Z; He B; Zhang Z; Wang J
    Abdom Radiol (NY); 2017 Aug; 42(8):2079-2088. PubMed ID: 28337521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CEUS in hepatocellular carcinoma and intrahepatic cholangiocellular carcinoma in 320 patients - early or late washout matters: a subanalysis of the DEGUM multicenter trial.
    Wildner D; Bernatik T; Greis C; Seitz K; Neurath MF; Strobel D
    Ultraschall Med; 2015 Apr; 36(2):132-9. PubMed ID: 25812115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocellular Carcinoma: Retrospective Evaluation of the Correlation Between Gadobenate Dimeglumine-Enhanced Magnetic Resonance Imaging and Pathologic Grade.
    Huang X; Xiao Z; Zhang Y; Lin N; Xiong M; Huang X; Chen Q; Cao D
    J Comput Assist Tomogr; 2018; 42(3):365-372. PubMed ID: 29369947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravoxel incoherent motion diffusion-weighted MR imaging of hepatocellular carcinoma: correlation with enhancement degree and histologic grade.
    Woo S; Lee JM; Yoon JH; Joo I; Han JK; Choi BI
    Radiology; 2014 Mar; 270(3):758-67. PubMed ID: 24475811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement patterns of hepatocellular carcinoma at contrast-enhanced US: comparison with histologic differentiation.
    Jang HJ; Kim TK; Burns PN; Wilson SR
    Radiology; 2007 Sep; 244(3):898-906. PubMed ID: 17709836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential Diagnosis of Arterial Phase Enhanced Hepatic Inflammatory Lesions and Hepatocellular Carcinomas with Contrast-enhanced Ultrasound.
    Yang W; Yan K; Wang S; Dai Y; Wu W; Yin SS; Chen MH
    Ultrasound Med Biol; 2016 Jan; 42(1):82-91. PubMed ID: 26456578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.